Dose delivery characteristics and lung deposition of indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) and IND/MF via Breezhaler device: An Alberta Idealised Throat (AIT) evaluation

J. Jauernig (Basel, Switzerland), K. Fiebich (Basel, Switzerland), D. Singh (Basel, Switzerland), X. Jaumont (Basel, Switzerland), K. Mezzi (Basel, Switzerland), X. Jaumont (La Madeleine, France)

Source: International Congress 2022 – Chronic airway diseases and infections: management and prevalence

Session: Chronic airway diseases and infections: management and prevalence
Session type: Thematic Poster
Number: 2414

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Jauernig (Basel, Switzerland), K. Fiebich (Basel, Switzerland), D. Singh (Basel, Switzerland), X. Jaumont (Basel, Switzerland), K. Mezzi (Basel, Switzerland), X. Jaumont (La Madeleine, France). Dose delivery characteristics and lung deposition of indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) and IND/MF via Breezhaler device: An Alberta Idealised Throat (AIT) evaluation. 2414

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.